David Deaton, chief, Vascular and Endovascular Surgery, MedStar Georgetown University Hospital, Washington, DC, USA, presented on the endostapling technology and aortic neck dilatation after EVAR at the Vascular Annual Meeting in National Harbor, USA.
The new Crux inferior vena cava filter can be implanted and retrieved safely and shows a low rate of pulmonary embolism, Anthony J Comerota, director, Jobst Vascular Institute, adjunct professor of Surgery, University of Michigan, USA, told delegates at the Vascular Annual Meeting (7–9 June 2012). He spoke about new developments with inferior vena cava filters at the conference in National Harbor, USA.
For many diabetics, monitoring their condition involves much more than adhering to a routine of glucose sensing and insulin injections. It also entails carefully monitoring the ongoing toll this disease takes on their body.
A new study published in the September print issue of the Journal of Vascular Surgery reveals that rural and urban patients have equivalent access to endovascular aneurysm repair (EVAR) care from vascular surgeons, increased referral to high-volume hospitals and improved outcomes after repair.
Twelve-month results from the CALCIUM 360° study have shown that orbital atherectomy with balloon angioplasty (BA) provide significantly lower major serious adverse events (major amputation, all-cause mortality, and TLR/TVR) than balloon angioplasty alone when used in the treatment of calcified infrapopliteal arteries in patients with critical limb ischaemia.
A new study raises a cautionary note about the increasing use of a minimally invasive procedure to repair ruptured abdominal aortic aneurysms, according to vascular surgeon Dr. Jae Sung Cho of Loyola University Medical Center.
Depression was linked with an increased risk of peripheral arterial disease (PAD) in a study of more than 1,000 men and women with heart disease conducted by researchers at the San Francisco VA Medical Center and the University of California, San Francisco, USA. Results of a sub-analysis from The Heart and Soul study were recently published on the Journal of the American Heart Association (online version).
Sapheon announced one year data in a 38-patient clinical study of the VenaSeal Sapheon Closure System, an advanced approach to the treatment of saphenous vein disease based on a proprietary medical adhesive.
The US Food and Drug Administration (FDA) has approved the Omnilink Elite Vascular Balloon-Expandable Stent System (Abbott) for the treatment of iliac arterial disease. The FDA approval is supported by positive clinical data from the MOBILITY (Omnilink Elite or Absolute Pro Stent used in the iliac artery) study. The MOBILITY study demonstrated that Omnilink Elite is safe and effective even in difficult-to-treat patients with severely calcified lesions.
On 8 August, the UK’s National Institute of Health and Clinical Excellence (NICE) published a clinical guideline on the diagnosis and management of lower limb peripheral arterial disease.
Madrid, agosto de 2012.- Sanitas Hospitales abre una nueva unidad para el tratamiento específico del pie diabético, un trastorno que afecta a los pies en forma de heridas y úlceras, y que es muy común en los pacientes con diabetes. Esta unidad implementará programas de prevención, ya que un correcto control de la diabetes es capaz de prevenir, retrasar y disminuir su aparición. La nueva unidad se encuentra ubicada en un entorno multidisciplinar que involucra a varias especialidades, y que engloba al Hospital Sanitas la Zarzuela, Sanitas la Moraleja, el Centro Médico Milenium Conde Duque y el Centro Médico Milenium Reina Victoria.
Phosphate binders can lower serum phosphorus levels for patients with chronic kidney disease (CKD), but they may also increase vascular calcification, researchers found.
Novel Platform Based Technology Combines Multiple Functions in Single Device. Acquisition includes Portfolio of FDA 510(k) Cleared Catheters for Dialysis Access and Peripheral Angioplasty
Agreement targets vein practices in U.S., 20 other countries Patented, head-mounted vascular imaging device offers practitioners the first truly hands-free, portable system for locating veins A powerful tool for performing sclerotherapy and phlebectomy
Angioslide, a provider of embolic capture angioplasty solutions, has announced the successful deployment of a 3X100mm Proteus device for treating peripheral artery disease in below-the-knee (BTK) vasculature at Community Hospital in Munster, USA. Accommodating a 0.014” guide-wire, the new device allows physician to perform a PTA revascularisation in BTK vessels while capturing and removing embolic particles.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos